Top Markets
Coin of the day
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Classifica tra le azioni #38647
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Prezzo delle azioni
$0.09
Ultima sincronizzazione: 2026-07-28
Capitalizzazione di mercato
$876.21K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-97.79%
Paese
US
Scambia BNB Plus Corp. (BNBX)

Categoria

Storico del rendimento da dividendi per BNB Plus Corp. (BNBX)
Il rendimento da dividendi (TTM) di BNB Plus Corp. (simbolo azionario: BNBX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per BNB Plus Corp. (BNBX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE